TRDA FY 2021 Earnings — Entrada Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TRDAEntrada Therapeutics, Inc.

$502M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$51M

Net Income

-$51M

EPS (Diluted)

$-1.60

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$55M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$306M

Total Liabilities

$7M

Stockholders' Equity

$299M

Cash & Equivalents

$291M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$326,000	+100.0%
Operating Income	-$51M	-$27M	-91.7%
Net Income	-$51M	-$27M	-92.9%